Neuromed Topical Anesthetic Cream
NDC Package 54723-300-06
Package Information
Neuromed Topical Anesthetic (lidocaine hydrochloride) cream is for adults and children two-years or older: Apply to affected area not more than 3 or 4 times daily. Children under 2 years of age: consult a physician. Apply in a circular motion for 50 to 60 seconds. This formulation utilizes a cream delivery system. Marketed by Sambria Pharmaceuticals, this product is identified by NDC 54723-300 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1421893 - lidocaine 4 % Topical Cream
- RxCUI: 1421893 - lidocaine 40 MG/ML Topical Cream
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 54723 - Sambria Pharmaceuticals
- 54723-300 - Neuromed Topical Anesthetic
- 54723-300-06 - 2 g in 1 PACKAGE
- 54723-300 - Neuromed Topical Anesthetic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54723-300). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54723-300-06 identifies a specific commercial package of 2 g in 1 package of Neuromed Topical Anesthetic 7, a human over the counter drug labeled by Sambria Pharmaceuticals. This cream is formulated for topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sambria Pharmaceuticals on August 01, 2016. The current certification is valid through December 31, 2026.
How is this Sambria Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54723030006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.